Invention Grant
- Patent Title: Disease therapy using a tolerogenic pharmaceutical preparation
-
Application No.: US14759452Application Date: 2014-01-07
-
Publication No.: US10653758B2Publication Date: 2020-05-19
- Inventor: Sylvain Perruche , Philippe Saas , Francis Bonnefoy
- Applicant: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) , ETABLISSEMENT FRANCAIS DU SANG , UNIVERSITE DE FRANCHE-COMTE , CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE BESANCON
- Applicant Address: FR Paris FR La Plaine Saint Denis FR Besacon FR Besacon
- Assignee: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM),ETABLISSEMENT FRANCAIS DU SANG,UNIVERSITE DE FRANCHE-COMTE,CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE BESANC̨ON
- Current Assignee: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM),ETABLISSEMENT FRANCAIS DU SANG,UNIVERSITE DE FRANCHE-COMTE,CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE BESANC̨ON
- Current Assignee Address: FR Paris FR La Plaine Saint Denis FR Besacon FR Besacon
- Agency: Oliff PLC
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@3c021f7d
- International Application: PCT/EP2014/050167 WO 20140107
- International Announcement: WO2014/106666 WO 20140710
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K35/15
Abstract:
Provided herein is a method for treating or preventing a pathological immune response comprising administering a supernatant obtainable from co-culture of phagocytes with apoptotic cells.
Public/Granted literature
- US20150343039A1 DISEASE THERAPY USING A TOLEROGENIC PHARMACEUTICAL PREPARATION Public/Granted day:2015-12-03
Information query
